https://doi.org/10.1007/s00210-025-04482-4
M
Muhammad Ansab
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
32
Citations
3
h-index
0
i10-index
Muhammad Ansab is an academic researcher from Services Institute of Medical Sciences. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Lung Cancer Treatments and Mutations & Atrial Fibrillation Management and Outcomes. The author has an h-index of 3, co-authored 18 publications.
Papers by this author
worksIntravenous thrombolysis as an adjunct to endovascular thrombectomy in acute basilar artery occlusion: a GRADE-assessed systematic review and meta-analysis
2025 · Naunyn-Schmiedeberg s Archives of Pharmacology · 6 citations
Extended reduced versus full-dose treatment with factor Xa inhibitors in patients with venous thromboembolism: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials
2025 · Naunyn-Schmiedeberg s Archives of Pharmacology · 5 citations
https://doi.org/10.1007/s00210-025-04388-1
Evaluating the risks and benefits of continuing versus withholding renin–angiotensin system inhibitors: a systematic review and meta-analysis with trial sequential analysis
2025 · BJA Open · 3 citations
https://doi.org/10.1016/j.bjao.2025.100405
Safety and Efficacy of Triple Therapy Containing Encorafenib, Cetuximab, and Binimetinib for BRAF V600E-Mutated Colorectal Cancer: a Systematic Review and Meta-Analysis
2026 · Journal of Gastrointestinal Cancer · 0 citations
https://doi.org/10.1007/s12029-026-01426-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat